Gimeracil

Gimeracil Impurities

Gimeracil is a potent dihydropyrimidine dehydrogenase (DPD) inhibitor that is widely used in combination therapy with fluoropyrimidines for the treatment of solid tumors. Its impurity profile includes structurally related analogs, residual solvents, and degradation products. It is well known that the pharmaceutical impurities can be formed under stress conditions such as hydrolysis, oxidation, and photolysis. Typical degradation pathways of Gimeracil may involve hydrolytic cleavage of the pyrimidine ring, oxidative modification of the heteroaryl substituents, and rearrangement of functional groups within the DPD-binding scaffold. These impurities may affect the potency, stability, and safety of the drug. Therefore, all the Gimeracil related impurities must be structurally characterized and qualified according to ICH guidelines for toxicological assessment and analytical validation.

Gimeracil EP Impurities

We provide the pharmacopeial and non-pharmacopeial Gimeracil impurity compounds that are available in compliance with European Pharmacopoeia (EP) specifications. These standards support analytical method development, impurity profiling, and long-term stability studies. The EP traceable materials are supplied with validated analytical data, including purity, structural confirmation, and spectral characterization.

Gimeracil Related Compounds

Structurally related compounds and synthetic analogs of Gimeracil are included for impurity identification, toxicological qualification, and regulatory submission. Additionally, these related substances are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations. Thus, the Gimeracil related substances are essential for understanding the impurity profile and ensuring compliance with regulatory limits.

Gimeracil Impurity Reference Standards

We also supply the Gimeracil impurity reference standards that are provided with validated analytical data, including purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. EP/USP traceable compounds are available upon request and are routinely re-tested to ensure consistency and reliability.